Abstract
Present study was carried out to examine effects of nanopowdered chitosan on antidiabetic activity in db/db mice. Twenty-eight 8-week-old mice were divided into 4 groups: (1) control, nondiabetic control mice; (2) group 1, diabetic control mice with not treated chitosans; (3) group 2, diabetic mice given 2% powdered chitosan; and (4) group 3, diabetic mice given 2% nanopowdered chitosan. The serum glucose in group 3 reduced by 56%, as compared to group 2 (28%). The total serum cholesterol in group 3 decreased by 31.6%, while group 2 reduced by 18.2%. Triglyceride was decreased by 33.6% in group 3 and by 22.5% in group 2. The insulin of group 2 and 3 were significantly increased by 51.7 and 92.9%, respectively. Only group 3 was recovered from the β-cell destruction. Based on the result of the study, it is suggested that nanopowdered chitosan has higher antidiabetic activities than powdered.
Similar content being viewed by others
References
Lee HW, Park YS, Choi JW, Yi SY, Shin WS. Antidiabetic effects of chitosan oligosaccharides in neonatal streptozotocin-induced noninsulin-dependent diabetes mellitus in rats. Biol. Pharm. Bull. 26: 1100–1103 (2003)
Kumar SG, Rahman MA, Lee SH, Hwang HS, Kim HA, Yun JW. Plasma proteome analysis for anti-obesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mice. Proteomics 9: 2149–2162 (2009)
Yao HT, Huang SY, Chiang MT. A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats. Food Chem. Toxicol. 46: 1525–1534 (2008)
Hayashi K, Ito M. Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice. Biol. Pharm. Bull. 25: 188–192 (2002)
Kawasaki F, Masafumi M, Kanda Y, Inoue H, Kaku K. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice. Am. J. Physiol. -Endoc. M. 288: E510–E518 (2004)
Kargar C, Ktorza A. Anatomical versus functional β-cell mass in experimental diabetes. Diabetes Obes. Metab. 10(Suppl 4): 43–53 (2008)
Pillai CKS, Paul W, Sharma CP. Chitin and chitosan polymers: Chemistry, solubility, and fiber formation. Prog. Polym. Sci. 34: 641–678 (2009)
Shu S, Zhang X, Teng D, Wang Z, Li C. Polyelectrolyte nanoparticles based on water-soluble chitosan-poly (l-aspartic acid)-polyethylene glycol for controlled protein release. Carbohyd. Res. 344: 1197–1204 (2009)
Sugano M, Fujikawa T, Hiratsuji Y, Nakashima K, Furada N, Hasegawa YA. A novel use of chitosan as a hypocholesterolemic agent in rats. Am. J. Clin. Nutr. 33: 787–793 (1980)
Jenning CD, Boleyn K, Bridges SR, Wood PJ, Anderson JW. A comparison of the lipid-lowering and intestinal morphological effects of cholestyramine, chitosan, and oat gum in rats. P. Soc. Exp. Biol. Med. 189: 13–20 (1988)
Simunek J, Bartonova H. Effect of dietary chitin and chitosan on cholesterolemic of rats. Acta Vet. Brno 74: 491–499 (2005)
Maezaki Y, Tsuji K, Nakagawa Y, Kawai Y, Akimoto M, Tsugita T. Hypocholesterolemic effect of chitosan in adult males. Biosci. Biotech. Bioch. 57: 1439–1444 (1993)
Guerciolini R, Radu-Radulescu L, Boldrin M, Dallas J, Moore R. Comparative evaluation of fecal excretion induced by orlistat and chitosan. Obes. Res. 29: 364–367 (2001)
Kondo Y, Nakatani A, Hayash K, Ito M. Low molecular weight chitosan prevents the progression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice. Biol. Pharm. Bull. 23: 1458–1464 (2000)
Rasenack N, Muller BW. Micron-size drug particles: Common and novel micronization techniques. Pharm. Dev. Technol. 9: 1–13 (2004)
Park HS, Jeon BJ, Ahn J, Kwak HS. Effects of nanocalcium supplemented milk on bone calcium metabolism in ovariectomized rats. Asian-Austral. J. Anim. Sci. 20: 1266–1271 (2007)
Seo MH, Lee SY, Chang YH, Kwak HS. Physicochemical, microbial, and sensory properties of yogurt supplemented with nanopowdered chitosan during storage. J. Dairy Sci. doi: 10.3168/jds.2009-2520 (2009)
Nagappa AN, Thakurdesai PA, Venkat Rao N, Singh J. Antidiabetic activity of Terminalia catapa Linn fruits. J. Ethnopharmacol. 88: 45–50 (2003)
Nordtveit RJ, Vaarum KM, Smidsroed O. Degradation of partially N-acetylated chitosans with hen egg white and human lysozyme. Carbohyd. Polym. 29: 163–167 (1996)
Park JH, Hong EK, Ahn J, Kwak HS. Properties of nanopowdered chitosan and its cholesterol lowering effects in rats. Food Sci. Biotechnol. 19: in press (2010)
Liu J, Zhang J, Xia W. Hypocholesterolemic effects of different chitosan samples in vitro and in vivo. Food Chem. 107: 419–425 (2008)
Zhou K, Xia W, Zhang C, Yu L. In vitro binding of bile acids and triglycerides by selected chitosan preparations and their physicochemical properties. LWT-Food Sci. Technol. 38: 1087–1092 (2006)
Asgary S, Parkhideh S, Solhpour A, Madani H, Mahzouni P, Rahimi P. Effect of ethanolic extract of Juglans regia L. on blood sugar in diabetes-induced rats. J. Med. Food 11: 533–538 (2008)
Malaisse WJ. Metabolic signaling of insulin secretion. Diabetes Rev. 4: 145–149 (1996)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seo, M.H., Park, J.H. & Kwak, HS. Antidiabetic activity of nanopowdered chitosan in db/db mice. Food Sci Biotechnol 19, 1245–1250 (2010). https://doi.org/10.1007/s10068-010-0178-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10068-010-0178-8